Rhythm Pharmaceuticals (RYTM +0.8%) appoints David Meeker, the company's chairman as the President and CEO, effective immediately.
Dr. Meeker succeeds Hunter Smith, the Company’s Interim President & CEO and CFO, who will continue in his role as CFO.
Dr. Meeker has served as Chairman of Rhythm Pharmaceuticals since April 2017 and as board member since November 2015. Most recently, he served as President and CEO of KSQ Therapeutics.
MG+M The Law Firm (MG+M) is pleased to announce that it has elevated attorneys Stephanie M. Chesney
Burns & Levinson announced today that well-known plaintiff employment litigator Beth R. Myers has joined the firm
BayCoast Bank is delighted to announce Nicole Almeida as Senior Vice President, Chief Diversity Officer (CDO)
BayCoast Bank is pleased to announce Robert Bergdoll of Attleboro, Massachusetts, as First Vice President Marketing Director
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2026 citybuzz
